Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02405572 · ClinicalTrials.gov registry record · NA
Feeding Tolerance Evaluation
A NA study of Healthy, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 2
- Study locations
NCT02405572: Completed NA study of Healthy, sponsored by Société des Produits Nestlé (SPN).
NCT02405572 is a NA study of Healthy that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 43 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02405572, a NA study of Healthy, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 2
- Study locations
Study Summary
Crossover study of 2 infant formulas
Primary Outcome
caregivers will document on diary records
Conditions Studied
Interventions
- OTHER infant formula
Study Locations (2)
Kentucky
- Pedia Research - Owensboro
Utah
- Tanner Clinic - Layton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2015-02 |
| Phase | NA |
What the finished NCT02405572 record still lists
NCT02405572 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which infant formula is the first listed.
NCT02405572 reports a single indexed study location in Kentucky, Utah.
Frequently Asked Questions
What is clinical trial NCT02405572 about?
NCT02405572 is a clinical study titled "Feeding Tolerance Evaluation". Crossover study of 2 infant formulas
What is the current status of trial NCT02405572?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2015-02.
What conditions does trial NCT02405572 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT02405572?
The interventions under investigation include: infant formula (OTHER).
Who is sponsoring clinical trial NCT02405572?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02405572 being conducted?
This trial has 2 study locations across Kentucky, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02405572's enrollment target sits among peer trials
43 522nd of 1090 higher than 567 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia